53 filings
8-K
XGN
Exagen Inc
26 Apr 24
Exagen Inc. Announces Changes to the Board of Directors
8:32am
8-K
XGN
Exagen Inc
18 Mar 24
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
8:00am
8-K
XGN
Exagen Inc
8 Jan 24
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
8:00am
8-K
XGN
Exagen Inc
11 Dec 23
Departure of Directors or Certain Officers
4:05pm
8-K
XGN
Exagen Inc
17 Nov 23
Entry into a Material Definitive Agreement
4:30pm
8-K
mg64j
13 Nov 23
Exagen Inc. Reports Strong Third Quarter 2023 Results
4:05pm
8-K
hzz2x zf1gtfv3y1cd7
26 Oct 23
Entry into a Material Definitive Agreement
4:05pm
8-K
ljap vuk2gh3s5dh
7 Aug 23
Exagen Inc. Reports Strong Second Quarter 2023 Results
8:00am
8-K
o64 0b0nfo
24 Jul 23
Exagen Inc. Appoints Paul Kim to Board of Directors
4:05pm
8-K
s1xlm
14 Jun 23
Submission of Matters to a Vote of Security Holders
4:50pm
8-K
s9nrrv6
15 May 23
Exagen Inc. Reports First Quarter 2023 Results
4:05pm
8-K
eo0 wi09rld2ihh
4 May 23
Entry into a Material Definitive Agreement
9:00am
8-K
w10mfpzp0i43
23 Mar 23
Departure of Directors or Certain Officers
9:00am
8-K
f4abbt nmg3yd5yb
20 Mar 23
Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
4:05pm
8-K
9uvcf m91s34gock8uy
23 Jan 23
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
9:00am
8-K
pjmge
9 Jan 23
Results of Operations and Financial Condition
9:00am
8-K
t6lxizfh814mzebigy7
5 Dec 22
Cost Associated with Exit or Disposal Activities
4:22pm
8-K
n4z1unns63av
14 Nov 22
Exagen Inc. Reports Third Quarter 2022 Results
4:08pm
8-K
bzva73q782
20 Oct 22
Exagen Announces Appointment of John Aballi as CEO
4:05pm
8-K
xe8 6e1dklat
15 Sep 22
Entry into a Material Definitive Agreement
4:03pm